IGF-1LR3: A Molecular Research Tool

Reviewed for accuracy by the Gorilla Research Labs research team · 2026-07-04

PEPTIDE RESEARCH IGF-1LR3: A Molecular Research Tool IGF-1LR3 is a synthetic analog of Insulin-like Growth Factor-1, engineered for use in laboratory settings to investigate the signaling pathways mediated by the IGF-1 receptor.

Overview & Classification

IGF-1LR3 (Long R3 IGF-1) is a synthetic protein sequence categorized as a peptide research tool. It is a modified version of the endogenous Insulin-like Growth Factor-1, characterized by the substitution of an arginine for a glutamic acid at position 3 and the extension of the N-terminus by 13 amino acids. This structural modification is intended to alter the binding kinetics of the molecule relative to its endogenous counterpart. In biochemical research, it is classified as a growth factor analog used to probe cell signaling cascades in controlled environments. For specific technical specifications, including molecular weight, sequence verification, and structural data, researchers are advised to refer to the batch-specific Certificate of Analysis (COA) or public chemical databases such as PubChem.

Molecular Target & Mechanism

The primary molecular target of IGF-1LR3 is the Type 1 Insulin-like Growth Factor Receptor (IGF-1R), a receptor tyrosine kinase. In laboratory models, the molecule acts as a ligand that initiates the autophosphorylation of the receptor. Upon binding to the IGF-1R, the molecule is reported to trigger intracellular signaling cascades, most notably the PI3K/AKT/mTOR pathway and the MAPK/ERK pathway. These pathways are central to the regulation of cellular processes such as proliferation, differentiation, and survival in vitro. The structural modification in the LR3 variant is documented to decrease the binding affinity of the molecule for IGF-binding proteins (IGFBPs). In physiological systems, IGFBPs sequester endogenous IGF-1, limiting its interaction with the receptor. By reducing this interaction, the LR3 variant remains available for receptor binding for an extended duration in cell culture media compared to the native peptide.

Why Researchers Use It

IGF-1LR3 is utilized in laboratory settings as a specialized tool to probe the mechanics of receptor-ligand interactions. Because of its reduced affinity for binding proteins, it serves as a stable probe for observing sustained signaling activation in cell culture. Researchers employ this molecule to study the kinetics of tyrosine kinase receptor signaling. It allows for the investigation of how specific signaling pathways are activated and maintained under controlled, serum-reduced, or serum-free conditions in vitro. • To assess the activation thresholds of the IGF-1R complex. • To study the divergence of PI3K vs. MAPK signaling outputs. • To observe cellular responses to sustained receptor stimulation.

Research Context

Laboratory research involving IGF-1LR3 is situated within the broader field of cellular biology and signal transduction. The focus of such investigations is typically the elucidation of how growth factor signaling influences cellular behavior in isolation. Studies involving this compound often examine the role of the IGF-1R in regulating cell cycle progression. By modulating the availability of the ligand, researchers can observe how shifts in signaling intensity correlate with changes in transcriptional activity or protein synthesis within the cell model. The molecule is also used to study the cross-talk between the IGF-1R and other receptors, such as the insulin receptor or various integrins, providing data on the complexity of cellular communication networks.

Handling, Stability & Storage for Laboratory Use

IGF-1LR3 is typically supplied as a lyophilized powder. For laboratory handling, it is recommended to reconstitute the peptide using an appropriate buffer, such as 10mM acetic acid or a neutral phosphate-buffered saline (PBS) containing a carrier protein like BSA, to ensure stability and prevent adsorption to container surfaces. Once reconstituted, the solution should be stored in small aliquots at -20°C or -80°C. Repeated freeze-thaw cycles should be avoided, as this may lead to the degradation of the peptide sequence and loss of its binding efficacy. Researchers should maintain strict aseptic techniques during handling to prevent microbial contamination of the peptide stock. Always refer to the specific storage instructions provided on the product label or the accompanying COA.

Purity & Analytical Verification

High-purity IGF-1LR3 is essential for reliable experimental results. Analytical verification is typically performed using High-Performance Liquid Chromatography (HPLC) to assess the chemical purity of the peptide, and Mass Spectrometry (MS) to confirm the molecular identity. A COA is provided with each batch to document these analytical findings. Researchers should review the COA to ensure that the purity levels meet the requirements of their specific experimental design, as impurities can introduce variables that interfere with receptor binding or trigger unintended cellular responses.

How it Relates to Other Compounds in its Research Class

IGF-1LR3 belongs to the broader class of growth factor analogs. It is frequently compared in laboratory literature to native IGF-1 and IGF-2. While these molecules share structural homology and target the same receptor family, they differ in their binding kinetics and interaction with IGFBPs. Other related research tools include IGF-1 DES (Des(1-3)IGF-1), which features a truncated N-terminus and exhibits a different binding profile. By comparing these variants, researchers can map the specific structural domains of the IGF-1 molecule that are responsible for receptor affinity and binding protein interaction.

Frequently Asked Research Questions

How does the LR3 mutation affect receptor affinity? The LR3 mutation is reported to reduce the molecule's affinity for IGF-binding proteins, which increases its bioavailability and residence time at the IGF-1 receptor interface in vitro. Is IGF-1LR3 suitable for all cell lines? Suitability depends on the expression levels of the IGF-1 receptor on the specific cell line being investigated. Researchers must confirm receptor presence via Western blot or qPCR before experimental application. How is the concentration of the peptide determined in solution? Concentration is typically verified through UV spectroscopy at 280nm using the specific extinction coefficient for the peptide, or through standardized protein assays. Can this peptide be used in vivo? This compound is strictly for in vitro laboratory research and in vivo research models as defined by institutional biosafety and animal welfare protocols. It is not for use in human subjects. Research use only — no structure/function or human-use claims are made. This information is intended for professional research purposes only.